David Toro Tobon

Thyroid molecular classifiers are likelihood ratios 📊, not magic verdicts 🎱 Our new @JAMAOnc viewpoint explores how to reclaim clinical reasoning and shared decision-making in the era of AI and automated testing @doctorjuanpa @vmontori @MayoClinicEndo jamanetwork.com/journals/jamao…

It was a pleasure to join the great group of the Mexican Society of Endocrinology, discussing management strategies for thyroid eye disease & RAI indications per new ATA guidelines, plus insights on redifferentiation at the International Forum of Thyroid Experts @SMNE_Oficial

INVITED REVIEW The evolving landscape of Thyroid Eye Disease: present and future by @davidtorot and Marius N Stan @mayoclinicendo EJE Volume 193, Issue 2, August 2025 👉 doi.org/10.1093/ejendo… ESE Members free via 👉 my.ese-hormones.org #endocrinology #thyroid

Reducing low-value thyroid ultrasounds is a critical step towards a more sustainable healthcare system. We hope our research helps inform strategies to reduce unnecessary procedures and improve patient care @EndoSocJournals @TheEndoSociety

While total healthcare costs over one year were similar between appropriate and inappropriate TUS groups, our findings highlight that inappropriate TUS is a significant and avoidable expense 🧵👇🏼

🚨 Our new paper on the overuse of thyroid ultrasounds (TUS) and its impact on healthcare costs is out now. We found that inappropriate TUS contributes to rising costs and unnecessary procedures. Full paper here: 👇🏼🧵 academic.oup.com/jes/article/9/… @doctorjuanpa @MayoClinicEndo

🏥Nearly 8% of adults who undergo a #thyroid ultrasound do not need to have one performed, according to @doctorjuanpa and researchers at @MayoClinic. @JAMAOto @HemOncToday @DoctorAngell healio.com/news/endocrino…

🚨In our new review on thyroid eye disease, we discuss advancements in current therapies, and what's coming down the road, and highlight the need for a more personalized, multidisciplinary approach to patient care. Read more here 👇🏼 @MayoClinicEndo @EJEndo academic.oup.com/ejendo/article…

Optimizing the use of thyroid US is a crucial step in improving patient safety and reducing low-value care!

The findings highlight a need for targeted interventions. Solutions include specialty specific education for clinicians and integrating clinical decision support tools into electronic health records to help guide appropriate ordering 🧵

🚨Our new research in @JAMAOto leverages AI to investigate the appropriateness of thyroid US use in 11,000 patients . It sheds light on a key driver of thyroid cancer over diagnosis and the resulting cascade of testing 🧵 jamanetwork.com/journals/jamao… @doctorjuanpa @MayoClinicEndo

Approximately 7.6% of thyroid ultrasonography (TUS) orders were inappropriate, particularly in younger patients, those with thyroid dysfunction, and orders originating from nonendocrinology specialties or online portals. ja.ma/3HjH6CZ

Our review on the advances in treatment of osteoporosis 👇🏼 @skhosla78 @dominiksaul88 @MayoClinicEndo

Thanks to @IrinaBancos, @LjiljanaMarina, @santoans, and our participants. And to @ESEndocrinology, @EYEScientists @ENSAT_news, @Soc_Endo, #EFF and others for helping us spread the word. This was a true team effort! @MayoClinicEndo @TheAACE @TheEndoSociety

The takeaway? Effective mentorship must be tailored to regional training culture. The US model excels in holistic, mentee-centered support, while the European model fosters efficiency and independence through structural guidance There's so much we can learn from each other!🧵

Excited to share our new paper exploring mentorship for endocrinology trainees in the US & Europe. Core message: Mentorship is universally beneficial, but the "secret sauce" for success looks very different on each side of the Atlantic 🧵 sciencedirect.com/science/articl…